Initiator Pharma AS (OSTO:INIT) Valuation Rank


OSTO:INIT Initiator Pharma AS OSTO:INIT
24 GF Score
Price kr2.65
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Initiator Pharma AS Valuation Rank Related Terms

OSTO:INIT
24GF Score
Initiator Pharma AS OSTO:INIT
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
24GF Score

Get the complete analysis for OSTO:INIT

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.65
Price